Enter your e-mail address below
to reset your password.
Please activate your registration
by clicking the link in the activation email
or click submit to resend the activation email.
Please check your spam folder too...
Check your mailbox to activate your registration.
Please check your spam folder too.
The board of Hungarian drug maker Egis will propose to shareholders payment of a HUF 120-per-share dividend on profit from the business year ended September 30, 2008, in line with its usual practice, the agenda for the company's AGM, published on Friday, reveals.
Egis's audited 2007/2008 IFRS profit and loss statement to be presented for the AGM's approval shows unconsolidated net profit of HUF 13.96 billion, 182% more than in the previous business year. (MTI – Econews)